Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.18
(-1.67%)
HKD 0.18
(-1.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 840 Thousand HKD | -2.1% |
| 2022 | 858 Thousand HKD | -18.6% |
| 2021 | 1.05 Million HKD | -24.98% |
| 2020 | 1.4 Million HKD | -13.27% |
| 2019 | 1.62 Million HKD | -7.27% |
| 2018 | 1.74 Million HKD | 25.23% |
| 2017 | 1.39 Million HKD | 91.88% |
| 2016 | 727 Thousand HKD | 23.43% |
| 2015 | 589 Thousand HKD | -35.84% |
| 2014 | 918 Thousand HKD | 212.98% |
| 2013 | -812.5 Thousand HKD | 89.86% |
| 2012 | -8 Million HKD | -153.26% |
| 2011 | 15.03 Million HKD | -55.12% |
| 2010 | 33.5 Million HKD | -18.24% |
| 2009 | 40.98 Million HKD | 254.9% |
| 2008 | 11.54 Million HKD | 42.41% |
| 2007 | 8.1 Million HKD | 88.82% |
| 2006 | 4.29 Million HKD | 2.07% |
| 2005 | 4.2 Million HKD | 22.19% |
| 2004 | 3.44 Million HKD | 34.65% |
| 2003 | 2.55 Million HKD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 840 Thousand HKD | -2.1% |
| 2023 Q1 | 190 Thousand HKD | -56.52% |
| 2023 Q2 | 380 Thousand HKD | 100.0% |
| 2023 Q3 | 230 Thousand HKD | -39.47% |
| 2023 Q4 | 460 Thousand HKD | 100.0% |
| 2022 Q3 | 218.5 Thousand HKD | -48.1% |
| 2022 Q4 | 437 Thousand HKD | 100.0% |
| 2022 Q1 | 210.5 Thousand HKD | -32.75% |
| 2022 Q2 | 421 Thousand HKD | 100.0% |
| 2022 FY | 858 Thousand HKD | -18.6% |
| 2021 FY | 1.05 Million HKD | -24.98% |
| 2021 Q1 | 370.5 Thousand HKD | -42.11% |
| 2021 Q2 | 741 Thousand HKD | 100.0% |
| 2021 Q3 | 156.5 Thousand HKD | -78.88% |
| 2021 Q4 | 313 Thousand HKD | 100.0% |
| 2020 Q2 | 765 Thousand HKD | 100.0% |
| 2020 FY | 1.4 Million HKD | -13.27% |
| 2020 Q3 | 320 Thousand HKD | -58.17% |
| 2020 Q1 | 382.5 Thousand HKD | -32.66% |
| 2020 Q4 | 640 Thousand HKD | 100.0% |
| 2019 FY | 1.62 Million HKD | -7.27% |
| 2019 Q1 | 526 Thousand HKD | 25.09% |
| 2019 Q2 | 1.05 Million HKD | 100.0% |
| 2019 Q3 | 284 Thousand HKD | -73.0% |
| 2019 Q4 | 568 Thousand HKD | 100.0% |
| 2018 Q3 | 420.5 Thousand HKD | -7.17% |
| 2018 Q4 | 420.5 Thousand HKD | 0.0% |
| 2018 Q2 | 453 Thousand HKD | 0.0% |
| 2018 Q1 | 453 Thousand HKD | 91.95% |
| 2018 FY | 1.74 Million HKD | 25.23% |
| 2017 FY | 1.39 Million HKD | 91.88% |
| 2017 Q3 | 236 Thousand HKD | -48.86% |
| 2017 Q2 | 461.5 Thousand HKD | 0.0% |
| 2017 Q1 | 461.5 Thousand HKD | 275.2% |
| 2017 Q4 | 236 Thousand HKD | 0.0% |
| 2016 Q4 | 123 Thousand HKD | 0.0% |
| 2016 Q1 | 240.5 Thousand HKD | 196.91% |
| 2016 Q2 | 240.5 Thousand HKD | 0.0% |
| 2016 Q3 | 123 Thousand HKD | -48.86% |
| 2016 FY | 727 Thousand HKD | 23.43% |
| 2015 Q1 | 213.5 Thousand HKD | -26.12% |
| 2015 Q3 | 81 Thousand HKD | -62.06% |
| 2015 Q2 | 213.5 Thousand HKD | 0.0% |
| 2015 Q4 | 81 Thousand HKD | 0.0% |
| 2015 FY | 589 Thousand HKD | -35.84% |
| 2014 Q1 | 170 Thousand HKD | 0.0% |
| 2014 FY | 918 Thousand HKD | 212.98% |
| 2014 Q4 | 289 Thousand HKD | 0.0% |
| 2014 Q3 | 289 Thousand HKD | 70.0% |
| 2014 Q2 | 170 Thousand HKD | 0.0% |
| 2013 FY | -812.5 Thousand HKD | 89.86% |
| 2013 Q2 | -240.5 Thousand HKD | 86.21% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q1 | -1.74 Million HKD | 58.78% |
| 2012 Q2 | 34 Thousand HKD | 0.0% |
| 2012 Q4 | -4.23 Million HKD | -12548.53% |
| 2012 Q3 | 34 Thousand HKD | 0.0% |
| 2012 FY | -8 Million HKD | -153.26% |
| 2011 FY | 15.03 Million HKD | -55.12% |
| 2010 FY | 33.5 Million HKD | -18.24% |
| 2009 FY | 40.98 Million HKD | 254.9% |
| 2008 FY | 11.54 Million HKD | 42.41% |
| 2007 FY | 8.1 Million HKD | 88.82% |
| 2006 FY | 4.29 Million HKD | 2.07% |
| 2005 FY | 4.2 Million HKD | 22.19% |
| 2004 FY | 3.44 Million HKD | 34.65% |
| 2003 FY | 2.55 Million HKD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 200.34 Million HKD | 99.581% |
| China Overseas Nuoxin International Holdings Limited | 35.69 Million HKD | 97.646% |
| Prosperous Future Holdings Limited | 71.05 Million HKD | 98.818% |
| Huasheng International Holding Limited | 154.45 Million HKD | 99.456% |
| Fourace Industries Group Holdings Limited | 95.5 Million HKD | 99.12% |
| Evergreen Products Group Limited | 233.23 Million HKD | 99.64% |
| EC Healthcare | 704.74 Million HKD | 99.881% |
| Ming Fai International Holdings Limited | 488.74 Million HKD | 99.828% |
| Blue Moon Group Holdings Limited | 4.35 Billion HKD | 99.981% |
| SuperRobotics Holdings Limited | 7.28 Million HKD | 88.463% |
| Takbo Group Holdings Limited | 75.4 Million HKD | 98.886% |
| Hyfusin Group Holdings Limited | 335.54 Million HKD | 99.75% |